Mavyret — Medica
Genotype 1 or 4 hepatitis C virus with renal impairment (eGFR < 30 mL/min or ESRD), pediatric (age ≥ 3 and < 18 years) – new start
Initial criteria
- Patient has met the Hepatitis C – Mavyret PA for PSM Policy criteria
Approval duration
as specified in the Hepatitis C – Mavyret PA for PSM Policy